Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Concordant clear cell “mesonephric” carcinoma of the bladder and lung adenocarcinoma with clear cell features – multiple primaries versus metastatic neoplasms: a case report

Authors: Sarmad H. Jassim, Amer Khiyami, Jane K. Nguyen, Santhi Ganesan, Joseph Tomashefski Jr., Joram Sawady

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Clear cell carcinoma of the bladder is a rare variant of urinary bladder adenocarcinoma. We report a case of a patient with clear cell carcinoma of the bladder and a concordant right upper lobe pulmonary adenocarcinoma with clear cell features, and we address the role of immunohistochemistry and cytogenetic analysis in distinguishing the two primary malignancies.

Case presentation

Our patient was a 59-year-old African American woman who presented with hematuria. Her past medical history included invasive mammary carcinoma and end-stage renal disease treated with hemodialysis. A computed tomographic urogram revealed a 3-cm polypoid bladder mass. A follow-up chest computed tomographic scan revealed a 1-cm right upper lobe nodule. The patient underwent transurethral biopsy and subsequent radical cystectomy, as well as a transthoracic core needle biopsy of the lung nodule. Histologically, the bladder tumor consisted of flat, cuboidal to columnar cells with clear or eosinophilic cytoplasm and a hobnail appearance, organized in tubulocystic and papillary patterns. The neoplastic cells were diffusely positive for α-methylacyl-coenzyme A racemase, cancer antigen 125, and cytokeratin 7; focally positive for cytokeratin 20, P53, and carcinoembryonic antigen; and negative for thyroid transcription factor 1. The lung tumor demonstrated a glandular architecture with mucin production (positive for mucin with mucicarmine and periodic acid-Schiff with diastase stain). The neoplastic cells were diffusely positive for cytokeratin 7, napsin A, and thyroid transcription factor 1, and they were negative for cytokeratin 20 and cancer antigen 125. Genetic testing of the pulmonary neoplasm demonstrated ARID2 genomic alterations.

Conclusions

The presence of clear cell features in both neoplasms raised the possibility of lung metastasis from the primary bladder tumor. However, the glandular architecture of the lung neoplasm along with its distinctive immunohistochemical and genetic profiles confirmed the presence of two separate primaries.
Literature
1.
go back to reference Olivia E, Trpkov K. Tumors of Mullerian type. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon, France: IARC Press; 2016. p. 115–6. Olivia E, Trpkov K. Tumors of Mullerian type. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon, France: IARC Press; 2016. p. 115–6.
2.
go back to reference Dow JA, Young Jr JD. Mesonephric adenocarcinoma of the bladder. J Urol. 1968;100(4):466–9.PubMed Dow JA, Young Jr JD. Mesonephric adenocarcinoma of the bladder. J Urol. 1968;100(4):466–9.PubMed
4.
go back to reference Pegoraro V, Cosciani-Cunico S, Graziotti PP, Dalla PP. Mesonephric adenocarcinoma of the bladder [in French]. J Urol (Paris). 1982;88(8):531–2. Pegoraro V, Cosciani-Cunico S, Graziotti PP, Dalla PP. Mesonephric adenocarcinoma of the bladder [in French]. J Urol (Paris). 1982;88(8):531–2.
5.
go back to reference Kanokogi M, Uematsu K, Kakudo K, Shimada K, Ikoma F. Mesonephric adenocarcinoma of the urinary bladder: an autopsy case. J Surg Oncol. 1983;22(2):118–20.CrossRefPubMed Kanokogi M, Uematsu K, Kakudo K, Shimada K, Ikoma F. Mesonephric adenocarcinoma of the urinary bladder: an autopsy case. J Surg Oncol. 1983;22(2):118–20.CrossRefPubMed
6.
go back to reference Minervini R, Urbano U, Fiorentini L. Mesonephric adenocarcinoma of bladder. Eur Urol. 1984;10(2):141–2.PubMed Minervini R, Urbano U, Fiorentini L. Mesonephric adenocarcinoma of bladder. Eur Urol. 1984;10(2):141–2.PubMed
7.
go back to reference Schultz RE, Bloch MJ, Tomaszewski JE, Brooks JS, Hanno PM. Mesonephric adenocarcinoma of the bladder. J Urol. 1984;132(2):263–5.PubMed Schultz RE, Bloch MJ, Tomaszewski JE, Brooks JS, Hanno PM. Mesonephric adenocarcinoma of the bladder. J Urol. 1984;132(2):263–5.PubMed
8.
go back to reference Hausdorfer GS, Chandrasoma P, Pettross BR, Carriere CA. Cytologic diagnosis of mesonephric adenocarcinoma of the urinary bladder. Acta Cytol. 1985;29(5):823–6.PubMed Hausdorfer GS, Chandrasoma P, Pettross BR, Carriere CA. Cytologic diagnosis of mesonephric adenocarcinoma of the urinary bladder. Acta Cytol. 1985;29(5):823–6.PubMed
9.
go back to reference Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra: a report of three cases and review of the literature. Am J Surg Pathol. 1985;9(11):816–26.CrossRefPubMed Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra: a report of three cases and review of the literature. Am J Surg Pathol. 1985;9(11):816–26.CrossRefPubMed
10.
go back to reference Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26(2):190–7.CrossRefPubMed Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26(2):190–7.CrossRefPubMed
11.
go back to reference Honda N, Yamada Y, Nanaura H, Fukatsu H, Nonomura H, Hatano Y. Mesonephric adenocarcinoma of the urinary bladder: a case report. Hinyokika Kiyo. 2000;46(1):27–31.PubMed Honda N, Yamada Y, Nanaura H, Fukatsu H, Nonomura H, Hatano Y. Mesonephric adenocarcinoma of the urinary bladder: a case report. Hinyokika Kiyo. 2000;46(1):27–31.PubMed
12.
go back to reference Signori G, Tonini G, Aulenti V, Taher B, Rad FK, Tosana M, et al. Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case. Urol Int. 2003;71(2):228–30.CrossRefPubMed Signori G, Tonini G, Aulenti V, Taher B, Rad FK, Tosana M, et al. Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case. Urol Int. 2003;71(2):228–30.CrossRefPubMed
13.
go back to reference Young RH, Scully RE. Nephrogenic adenoma: a report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract. Am J Surg Pathol. 1986;10(4):268–75.CrossRefPubMed Young RH, Scully RE. Nephrogenic adenoma: a report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract. Am J Surg Pathol. 1986;10(4):268–75.CrossRefPubMed
14.
go back to reference Ziade J, Cipolla B, Robert I, Staerman F, Corbel L, Guillé F, et al. Synchronous bladder metastasis of a clear-cell adenocarcinoma of the kidney. Acta Urol Belg. 1994;62(4):45–8.PubMed Ziade J, Cipolla B, Robert I, Staerman F, Corbel L, Guillé F, et al. Synchronous bladder metastasis of a clear-cell adenocarcinoma of the kidney. Acta Urol Belg. 1994;62(4):45–8.PubMed
15.
go back to reference Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998;29(12):1451–6.CrossRefPubMed Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998;29(12):1451–6.CrossRefPubMed
16.
go back to reference Lu J, Xu Z, Jiang F, Wang Y, Hou Y, Wang C, et al. Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review. World J Surg Oncol. 2012;10:33.CrossRefPubMedPubMedCentral Lu J, Xu Z, Jiang F, Wang Y, Hou Y, Wang C, et al. Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review. World J Surg Oncol. 2012;10:33.CrossRefPubMedPubMedCentral
17.
go back to reference Travis WD, Yatabe Y, Brambilla E, Ishikawa Y, Nicholson AG, Aisner SC, et al. Variants of adenocarcinoma. In: Travis WD, Marx A, Brambilla E, Nicholson A, Burke A, editors. WHO classification of tumors of the lung, pleura, thymus, and heart. 4th ed. Lyon, France: IARC Press; 2015. p. 43. Travis WD, Yatabe Y, Brambilla E, Ishikawa Y, Nicholson AG, Aisner SC, et al. Variants of adenocarcinoma. In: Travis WD, Marx A, Brambilla E, Nicholson A, Burke A, editors. WHO classification of tumors of the lung, pleura, thymus, and heart. 4th ed. Lyon, France: IARC Press; 2015. p. 43.
18.
go back to reference Vainrib M, Leibovitch I. Urological implications of concurrent bladder and lung cancer. Isr Med Assoc J. 2007;9(10):732–5.PubMed Vainrib M, Leibovitch I. Urological implications of concurrent bladder and lung cancer. Isr Med Assoc J. 2007;9(10):732–5.PubMed
19.
go back to reference Kruck S, Scharpf M, Stenzl A, Bedke J. A rare case of synchronous renal cell carcinoma of the bladder presenting with gross hematuria. Rare Tumors. 2013;5(2):72–4.PubMedPubMedCentral Kruck S, Scharpf M, Stenzl A, Bedke J. A rare case of synchronous renal cell carcinoma of the bladder presenting with gross hematuria. Rare Tumors. 2013;5(2):72–4.PubMedPubMedCentral
20.
go back to reference Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med. 2009;133(6):987–91.PubMed Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med. 2009;133(6):987–91.PubMed
21.
go back to reference Reis-Filho JS, Carrilho C, Valenti C, Leitão D, Ribeiro CA, Ribeiro SG, et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Pathol Res Pract. 2000;196(12):835–40.CrossRefPubMed Reis-Filho JS, Carrilho C, Valenti C, Leitão D, Ribeiro CA, Ribeiro SG, et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Pathol Res Pract. 2000;196(12):835–40.CrossRefPubMed
22.
go back to reference Manceau G, Letouzé E, Guichard C, Didelot A, Cazes A, Corté H, et al. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma. Int J Cancer. 2013;132(9):2217–21.CrossRefPubMed Manceau G, Letouzé E, Guichard C, Didelot A, Cazes A, Corté H, et al. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma. Int J Cancer. 2013;132(9):2217–21.CrossRefPubMed
Metadata
Title
Concordant clear cell “mesonephric” carcinoma of the bladder and lung adenocarcinoma with clear cell features – multiple primaries versus metastatic neoplasms: a case report
Authors
Sarmad H. Jassim
Amer Khiyami
Jane K. Nguyen
Santhi Ganesan
Joseph Tomashefski Jr.
Joram Sawady
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1295-2

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue